Bridge Biotherapeutics (Korea) Price on April 11, 2024
| 288330 Stock | KRW 3,920 35.00 0.88% |
If you're considering investing in Bridge Stock, it is important to understand the factors that can impact its price. As of today, the current price of Bridge Biotherapeutics stands at 3,920, as last reported on the 29th of December, with the highest price reaching 4,135 and the lowest price hitting 3,825 during the day. Bridge Biotherapeutics appears to be very steady, given 3 months investment horizon. Bridge Biotherapeutics secures Sharpe Ratio (or Efficiency) of 0.0403, which signifies that the company had a 0.0403% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Bridge Biotherapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Bridge Biotherapeutics' Mean Deviation of 5.99, risk adjusted performance of 0.0314, and Downside Deviation of 6.14 to double-check if our risk estimates are consistent with your expectations.
Bridge Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Bridge |
Sharpe Ratio = 0.0403
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 288330 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.4 actual daily | 74 74% of assets are less volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Bridge Biotherapeutics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bridge Biotherapeutics by adding it to a well-diversified portfolio.
Bridge Biotherapeutics Valuation on April 11, 2024
It is possible to determine the worth of Bridge Biotherapeutics on a given historical date. On April 11, 2024 Bridge was worth 4096.76 at the beginning of the trading date compared to the closed value of 4380.05. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bridge Biotherapeutics stock. Still, in general, we apply an absolute valuation method to find Bridge Biotherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bridge Biotherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bridge Biotherapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 4,177 | 4,387 | 4,082 | 4,264 | 417,882 | |
04/11/2024 | 4,097 | 4,576 | 4,010 | 4,380 | 496,987 |
| 4,438 | 4,554 | 4,242 | 4,518 | 285,382 |
| Backtest Bridge Biotherapeutics | | | Bridge Biotherapeutics History | | | Bridge Biotherapeutics Valuation | Previous | Next |
Bridge Biotherapeutics Trading Date Momentum on April 11, 2024
| On April 12 2024 Bridge Biotherapeutics was traded for 4,518 at the closing time. The highest price during the trading period was 4,554 and the lowest recorded bid was listed for 4,242 . The volume for the day was 285.4 K. This history from April 12, 2024 contributed to the next trading day price jump. The daily price change to the next closing price was 3.15% . The overall trading delta to the current price is 21.81% . |
Bridge Biotherapeutics Fundamentals Correlations and Trends
By evaluating Bridge Biotherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bridge Biotherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bridge financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bridge Biotherapeutics Stock history
Bridge Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bridge is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bridge Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bridge Biotherapeutics stock prices may prove useful in developing a viable investing in Bridge Biotherapeutics
Bridge Biotherapeutics, Inc., a clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide. The company was founded in 2015 and is headquartered in Seongnam, Korea. BRIDGE BIOTHERAPEUTICS is traded on Korean Securities Dealers Automated Quotations in South Korea.
Bridge Biotherapeutics Stock Technical Analysis
Bridge Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bridge Biotherapeutics Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
Bridge Biotherapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on KOSDAQ. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bridge Biotherapeutics December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Bridge Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bridge Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Bridge Biotherapeutics stock market strength indicators, traders can identify Bridge Biotherapeutics entry and exit signals to maximize returns
Bridge Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bridge Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Bridge Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bridge to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0314 | |||
| Jensen Alpha | 0.2728 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.0321 | |||
| Treynor Ratio | (0.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Bridge Stock analysis
When running Bridge Biotherapeutics' price analysis, check to measure Bridge Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bridge Biotherapeutics is operating at the current time. Most of Bridge Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bridge Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bridge Biotherapeutics' price. Additionally, you may evaluate how the addition of Bridge Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |